Brad Hively is Director of Oncology Institute, Inc.. Currently has a direct ownership of 676,203 shares of TOI, which is worth approximately $108,192. The most recent transaction as insider was on Jun 17, 2024, when has been sold 18,121 shares (Common Stock) at a price of $0.46 per share, resulting in proceeds of $8,335. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 676K
0% 3M change
0.75% 12M change
Total Value Held $108,192

Brad Hively Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2024
SELL
Sale (or disposition) back to the issuer
$8,335 $0.46 p/Share
18,121 Reduced 2.61%
676,203 Common Stock
May 22 2024
SELL
Sale (or disposition) back to the issuer
$11,325 $0.58 p/Share
19,526 Reduced 2.74%
694,324 Common Stock
Dec 26 2023
BUY
Grant, award, or other acquisition
-
42,652 Added 5.64%
713,850 Common Stock
Nov 21 2023
SELL
Sale (or disposition) back to the issuer
$56,648 $2.19 p/Share
25,867 Reduced 3.71%
671,198 Common Stock
Nov 17 2023
SELL
Open market or private sale
$56,000 $2.24 p/Share
25,000 Reduced 3.46%
697,065 Common Stock
Nov 17 2023
BUY
Exercise of conversion of derivative security
$21,250 $0.85 p/Share
25,000 Added 3.35%
722,065 Common Stock
Nov 14 2023
SELL
Sale (or disposition) back to the issuer
$64,809 $2.39 p/Share
27,117 Reduced 3.74%
697,065 Common Stock
Nov 13 2023
SELL
Open market or private sale
$118,440 $2.52 p/Share
47,000 Reduced 6.09%
724,182 Common Stock
Nov 13 2023
BUY
Exercise of conversion of derivative security
$39,950 $0.85 p/Share
47,000 Added 5.74%
771,182 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
168,512 Added 18.88%
724,182 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
103,469 Added 15.7%
555,670 Common Stock
Nov 15 2022
SELL
Sale (or disposition) back to the issuer
$19,727 $2.03 p/Share
9,718 Reduced 2.1%
452,201 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
108,469 Added 19.02%
461,919 Common Stock
Jan 12 2021
BUY
Grant, award, or other acquisition
-
353,450 Added 62.5%
212,070 Common Stock
BH

Brad Hively

Director
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI